glp 1 and biologics GLP-1 Receptor Agonist Market Size DNA-based delivery of incretin receptor

TRIUMPH-4 (December 2025) TRIUMPH-1 (May 21, 2026) Semaglutide STEP-1 Trial What Nearly Double the Weight Loss Means in Practice For a patient starting at 250 lbs: These numbers come from separate trials with different populations not a direct head-to-head comparison

3,5 Whereas injectable semaglutide achieved 15% mean weight loss at 68 weeks in the Semaglutide Treatment Effect in People with obesity (STEP-1) study, it requires subcutaneous administration

The clinical trial reported percentage weight loss rather than absolute weight, so researchers should calculate expected absolute weight changes based on the starting weight of their research subjects when designing study endpoints

Tsang says using a GLP-1 requires practicing self-awareness and patience over time if you expect to lose weight and keep it off